Developing an effective strategy for early detection of ovarian cancer remains one of the most significant unmet needs in the diagnosis and treatment of the disease. Approximately 22 000 cases of ovarian cancer are diagnosed each year among women in the United States.1 Similar to women with lung and pancreatic cancers, women with ovarian cancer are typically diagnosed in late stages, resulting in poor outcomes. For the 20% of patients with ovarian cancer diagnosed with stage I disease, 5-year survival rates are greater than 90%, whereas for the majority of women diagnosed with stage III or IV ovarian cancer, 5-year survival rates are approximately 17% to 39%.2
Lu KH. Screening for Ovarian Cancer in Asymptomatic Women. JAMA. 2018;319(6):557–558. doi:10.1001/jama.2017.21894
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.